Thursday, May 17, 2018

Shorter trastuzumab treatment for HER2+ breast cancer can be as effective, with fewer cardiac side-effects

  1. Shorter trastuzumab treatment for HER2+ breast cancer can be as effective, with fewer cardiac side-effects  Medical Xpress
  2. Test of Herceptin Finds Briefer Treatment Can Work, With Fewer Side Effects  WBUR
  3. Turning 40? You might want to skip this mammography primer from US News  HealthNewsReview.org
  4. For Women With Early Breast Cancer, Herceptin Treatment Can Be Much Shorter  New York TimesFull coverage

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Headlines